Key Details
Price
$9.60Annual Revenue
$315.66 MAnnual EPS
-$4.42Annual ROE
-40.80%Beta
1.35Events Calendar
Next earnings date:
Feb 27, 2025Recent quarterly earnings:
Nov 07, 2024Recent annual earnings:
Feb 27, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
INGN announces FDA clearance for the SIMEOX 200 Airway Clearance Device.
Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
Inogen (INGN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Inogen's overall third-quarter 2024 results continue to gain from higher business-to-business sales.
Call Start: 17:00 January 1, 0000 5:26 PM ET Inogen, Inc. (NASDAQ:INGN ) Q3 2024 Earnings Conference Call November 7, 2024, 5:00 PM ET Company Participants Ryan Peterson - Investor Relations Kevin Smith - President and CEO Mike Bourque - Chief Financial Officer Conference Call Participants Rohin Patel - JPMorgan Mike Matson - Needham Operator Welcome to Inogen's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
While the top- and bottom-line numbers for Inogen (INGN) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Inogen (INGN) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $1.97 per share a year ago.
INGN shows impressive momentum, driven by strong sales growth, an expanding product portfolio and significant advancements in portable oxygen technology.
Expanding product portfolio and high prospects for POC raise optimism for the INGN stock.
Expanding product portfolio and high prospects for POC raise optimism for the Inogen (INGN) stock.
FAQ
- What is the primary business of Inogen?
- What is the ticker symbol for Inogen?
- Does Inogen pay dividends?
- What sector is Inogen in?
- What industry is Inogen in?
- What country is Inogen based in?
- When did Inogen go public?
- Is Inogen in the S&P 500?
- Is Inogen in the NASDAQ 100?
- Is Inogen in the Dow Jones?
- When was Inogen's last earnings report?
- When does Inogen report earnings?
- Should I buy Inogen stock now?